Advancements of Biomarkers in Disability Studies

What is it about?

This book chapter provides a comprehensive exploration of the evolution, current status, and future directions of biomarkers and diagnostic technologies used in the assessment and management of disabilities. It traces the historical development of key diagnostic approaches, from early clinical observations to modern molecular, genetic, and imaging biomarkers. The volume critically examines recent advances in high-throughput technologies, bioinformatics, and artificial intelligence that are transforming disability diagnostics, and highlights emerging tools with potential for early detection, personalized intervention, and improved outcomes. By integrating multidisciplinary perspectives, the book offers valuable insights for researchers, clinicians, and policy makers working to advance precision medicine and inclusive healthcare for individuals with disabilities.

Featured Image

Photo by Jon Tyson on Unsplash

Photo by Jon Tyson on Unsplash

Why is it important?

Disabilities affect millions worldwide, yet accurate, early, and accessible diagnosis remains a major challenge in ensuring timely support, effective intervention, and inclusive care. Advances in biomarkers and diagnostic tools hold the key to transforming disability assessment by enabling objective, precise, and personalized evaluation that can guide clinical decisions and public health strategies. This book chapter is important because it bridges historical context with cutting-edge scientific progress, offering a comprehensive resource that highlights how innovations in molecular biology, genomics, imaging, and artificial intelligence are reshaping diagnostics for disabilities. It serves as a critical reference for researchers, clinicians, and policymakers aiming to improve diagnostic accuracy, promote health equity, and drive future innovation in disability care.

Perspectives